According to researchers writing in
As Dr.
The good news is a growing majority of Americans are expressing COVID-19 vaccine readiness. The increase in confidence follows news about the first two COVID-19 vaccines confirmed with over 95% efficacy and the subsequent emergency use authorizations (EUA) granted by the
Recent opinion research conducted by PhRMA[1], Gallup,
Another big story in Gallup's vaccine confidence numbers is the recent change by key subgroups. We have long seen significant differences in attitudes by gender, race, income, education and political party affiliation. Notably, the confidence gap has widened between
In line with these numbers is a growing appreciation for the significant value COVID-19 vaccines provide. In our survey noted above, 72% of American voters agree (39% strongly) that vaccines are key to ending the pandemic, and the public widely recognizes that vaccines will not only help save lives (62% likely to happen after a vaccination becomes available) but also restore core aspects of our day-to-day living, including the re-opening of schools (62% likely), businesses (61% likely) and restaurants (58% likely). Recent public polling reinforces theses trend with the Axios-Ipsos Coronavirus Index showing new urgency in plans to be vaccinated, and
As the biopharmaceutical industry continues to study new and ongoing vaccine candidates through clinical trials, continued education will be critical to recognizing the benefits of the vaccines. We also know there continues to be several important questions from the public about these vaccines. It is critical all health care stakeholders come together to share open, honest and transparent information to help instill confidence.
Contact:
Tel: (202) 835-3400
Web: www.PhRMA.org
(C) 2021 Electronic News Publishing, source